Filed: 5/12/2025ACC: 0001395064-25-000055
📋 What this filing means
TAKEDA PHARMACEUTICAL CO LTD filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $16.19M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$16.19M
Total AUM (reported)
20.13M
Total Shares
Allocation by class
COM$16.19M100.0%
Portfolio Concentration
Top 3$13.17M81.3%
4–10$3.01M18.6%
11–25$17.8K0.1%
Top 3 weight
81.3%
Top 10 weight
99.9%
Voting Authority Distribution
Total shares with voting rights: 20.13M
Sole
Full voting authority
20.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other11
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
HilleVax, Inc.
DFNDShares6.72M
TypeSH
Market value$9.75M
60.21%
Sole
6.72M
Shared
0.00
None
0.00
Ovid Therapeutics, Inc.
DFNDShares7.53M
TypeSH
Market value$2.35M
14.51%
Sole
7.53M
Shared
0.00
None
0.00
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)
DFNDShares1.48M
TypeSH
Market value$1.07M
6.59%
Sole
1.48M
Shared
0.00
None
0.00
Equillium, Inc.
DFNDShares1.82M
TypeSH
Market value$711.7K
4.40%
Sole
1.82M
Shared
0.00
None
0.00
American Well Corporation
DFNDShares77.73K
TypeSH
Market value$612.5K
3.78%
Sole
77.73K
Shared
0.00
None
0.00
Shattuck Labs, Inc.
DFNDShares515.62K
TypeSH
Market value$489.8K
3.02%
Sole
515.62K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
DFNDShares823.32K
TypeSH
Market value$442.9K
2.74%
Sole
823.32K
Shared
0.00
None
0.00
Turnstone Biologics
DFNDShares895.82K
TypeSH
Market value$367.3K
2.27%
Sole
895.82K
Shared
0.00
None
0.00
Rani Therapeutics Holdings, Inc.
DFNDShares203.19K
TypeSH
Market value$256.0K
1.58%
Sole
203.19K
Shared
0.00
None
0.00
Third Harmonic Bio, Inc.
DFNDShares36.84K
TypeSH
Market value$127.8K
0.79%
Sole
36.84K
Shared
0.00
None
0.00
Standard Biotools, Inc.
DFNDShares16.52K
TypeSH
Market value$17.8K
0.11%
Sole
16.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
HilleVax, Inc.DFND | COM | 6.72M | SH | $9.75M 60.21% | 6.72M | 0.00 | 0.00 |
Ovid Therapeutics, Inc.DFND | COM | 7.53M | SH | $2.35M 14.51% | 7.53M | 0.00 | 0.00 |
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)DFND | COM | 1.48M | SH | $1.07M 6.59% | 1.48M | 0.00 | 0.00 |
Equillium, Inc.DFND | COM | 1.82M | SH | $711.7K 4.40% | 1.82M | 0.00 | 0.00 |
American Well CorporationDFND | COM | 77.73K | SH | $612.5K 3.78% | 77.73K | 0.00 | 0.00 |
Shattuck Labs, Inc.DFND | COM | 515.62K | SH | $489.8K 3.02% | 515.62K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.DFND | COM | 823.32K | SH | $442.9K 2.74% | 823.32K | 0.00 | 0.00 |
Turnstone BiologicsDFND | COM | 895.82K | SH | $367.3K 2.27% | 895.82K | 0.00 | 0.00 |
Rani Therapeutics Holdings, Inc.DFND | COM | 203.19K | SH | $256.0K 1.58% | 203.19K | 0.00 | 0.00 |
Third Harmonic Bio, Inc.DFND | COM | 36.84K | SH | $127.8K 0.79% | 36.84K | 0.00 | 0.00 |
Standard Biotools, Inc.DFND | COM | 16.52K | SH | $17.8K 0.11% | 16.52K | 0.00 | 0.00 |